Literature DB >> 28539501

Reply to Plucinski et al., "Interpreting Data from Passive Surveillance of Antimalarial Treatment Failures".

Colin J Sutherland1,2, Effrossyni Gkrania-Klotsas3, Peter L Chiodini4,5.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28539501      PMCID： PMC5444137          DOI： 10.1128/AAC.00529-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.

Authors:  M B Reed; K J Saliba; S R Caruana; K Kirk; A F Cowman
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  Malaria resistance to non-artemisinin partner drugs: how to reACT.

Authors:  Donelly A van Schalkwyk; Colin J Sutherland
Journal:  Lancet Infect Dis       Date:  2015-04-12       Impact factor: 25.071

3.  The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin.

Authors:  M T Duraisingh; P Jones; I Sambou; L von Seidlein; M Pinder; D C Warhurst
Journal:  Mol Biochem Parasitol       Date:  2000-04-30       Impact factor: 1.759

4.  Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model.

Authors:  Leah A Walker; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

5.  High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.

Authors:  Klara Sondén; Katja Wyss; Irina Jovel; Antero Vieira da Silva; Anton Pohanka; Muhammad Asghar; Manijeh Vafa Homann; Lars L Gustafsson; Urban Hellgren; Anna Färnert
Journal:  Clin Infect Dis       Date:  2016-10-24       Impact factor: 9.079

6.  The Mu subunit of Plasmodium falciparum clathrin-associated adaptor protein 2 modulates in vitro parasite response to artemisinin and quinine.

Authors:  Gisela Henriques; Donelly A van Schalkwyk; Rebekah Burrow; David C Warhurst; Eloise Thompson; David A Baker; David A Fidock; Rachel Hallett; Christian Flueck; Colin J Sutherland
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

7.  pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.

Authors:  Colin J Sutherland; Paul Lansdell; Mandy Sanders; Julian Muwanguzi; Donelly A van Schalkwyk; Harparkash Kaur; Debbie Nolder; Julie Tucker; Hayley M Bennett; Thomas D Otto; Matthew Berriman; Trupti A Patel; Roderick Lynn; Effrossyni Gkrania-Klotsas; Peter L Chiodini
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

8.  Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT.

Authors:  Gisela Henriques; Rachel L Hallett; Khalid B Beshir; Nahla B Gadalla; Rachel E Johnson; Rebekah Burrow; Donelly A van Schalkwyk; Patrick Sawa; Sabah A Omar; Taane G Clark; Teun Bousema; Colin J Sutherland
Journal:  J Infect Dis       Date:  2014-07-03       Impact factor: 5.226

9.  Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.

Authors:  Julian Muwanguzi; Gisela Henriques; Patrick Sawa; Teun Bousema; Colin J Sutherland; Khalid B Beshir
Journal:  Malar J       Date:  2016-01-22       Impact factor: 2.979
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.